Product Overview

Lucicyp 50 Mg is a prescription medication that contains the active ingredient cyproterone acetate. It is formulated as oral tablets and is supplied in blister packs that each contain 50 tablets. The product is manufactured by Lucius Pharmaceuticals in Laos, a company that follows Good Manufacturing Practice (GMP) standards and conducts comprehensive quality‑control testing for identity, potency, and purity. Pack size options include 50, 100, and 200 tablets, allowing patients to select the quantity that best fits their treatment plan. Delivery typically takes 6 to 15 days depending on the shipping destination, making it a convenient option for those seeking reliable hormonal therapy.

What is Lucicyp 50 Mg (Cyproterone Acetate)?

Cyproterone acetate belongs to a class of drugs known as non‑steroidal anti‑androgens. The 50 mg strength is the most commonly used dosage for long‑term hormonal modulation. It works by binding to androgen receptors and blocking the action of testosterone at the cellular level, while also suppressing the hypothalamic‑pituitary‑gonadal axis, which leads to reduced endogenous testosterone production. This dual mechanism makes it effective for lowering circulating androgen levels in a variety of clinical settings.

Uses and Benefits

The therapeutic indications for Lucicyp 50 Mg include the management of hormone‑sensitive cancers such as prostate cancer, the treatment of severe acne, and the suppression of sexual drive in specific clinical contexts. By reducing serum testosterone, the drug can slow the growth of tumors that depend on androgen signaling. Patients with dermatologic conditions that are exacerbated by androgen activity often experience clearer skin and a decrease in lesion frequency.

In addition, clinicians sometimes incorporate cyproterone acetate into gender‑affirming care to reduce virilization in transgender women. The medication’s ability to both block receptors and lower hormone production provides a comprehensive approach to conditions that are driven by excess androgen activity.

How It Works

At the molecular level, cyproterone acetate competes with testosterone for binding sites on the androgen receptor, preventing the hormone from activating downstream signaling pathways. Simultaneously, it acts as an antagonist at luteinizing‑releasing hormone (LHRH) receptors, which reduces the release of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) from the pituitary gland. This cascade results in decreased testicular testosterone synthesis, leading to a measurable decline in circulating androgen levels.

Clinical studies have shown that a daily oral dose of 50 mg can reduce serum testosterone by up to 90 % after four weeks of therapy, although the exact magnitude of reduction may vary among individuals. Routine laboratory monitoring is recommended to ensure that testosterone remains within the target range prescribed by the treating physician.

Dosage Guidelines

Dosage of Lucicyp 50 Mg must be individualized based on the patient’s underlying condition, response to therapy, and tolerability. The usual starting dose for hormonal therapy is one tablet taken once daily, with adjustments made according to serum testosterone measurements and clinical response. Patients should be instructed to swallow the tablet whole with water and to avoid crushing or chewing the medication.

It is essential that dosage modifications are performed only under the supervision of a qualified healthcare professional. Abrupt discontinuation may lead to rebound increases in testosterone and could compromise therapeutic outcomes. If a dose is missed, the patient should not double the next dose but should resume the regular schedule as soon as possible.

Side Effects

Like all prescription medicines, Lucicyp 50 Mg can be associated with adverse effects. The most frequently reported side effects include hot flashes, decreased libido, and mild gastrointestinal discomfort such as nausea. Some patients may experience mood changes, including depression or anxiety, which necessitate close monitoring.

Less common but clinically significant adverse reactions include elevations in liver enzymes, electrolyte disturbances, and rare instances of thromboembolic events. Patients should have baseline liver function tests before therapy and repeat them periodically during treatment. Additional side effects reported in clinical practice include weight gain, mild edema, and occasional skin rash. In rare cases, hyper‑kalaemia has been observed, requiring periodic electrolyte checks.

Warnings and Precautions

Lucicyp 50 Mg is contraindicated in individuals with known hypersensitivity to cyproterone acetate or any of the excipients in the formulation. The medication should not be used during pregnancy or breastfeeding, as it may cause fetal abnormalities and affect milk composition.

Patients with a history of liver disease, severe renal impairment, or cardiovascular disease should be evaluated carefully before initiating therapy. Concomitant use of other anti‑androgens, certain antidepressants, or hormonal contraceptives may increase the risk of side effects and should be discussed with a physician. Because cyproterone acetate has been linked to an increased risk of blood clots, individuals with a personal or family history of thromboembolic disease should undergo a thorough cardiovascular assessment prior to treatment.

Routine laboratory monitoring, including complete blood counts and lipid profiles, is recommended every three to six months. For additional authoritative information, you may refer to resources such as the U.S. Food and Drug Administration (FDA), the MedlinePlus drug entry, the National Center for Biotechnology Information (NCBI) bookshelf, or the National Institutes of Health (NIH).

Frequently Asked Questions

1. What is the primary indication for Lucicyp 50 Mg?
Lucicyp 50 Mg is prescribed primarily to lower circulating testosterone levels in conditions such as hormone‑sensitive prostate cancer, severe acne, and certain gender‑affirming regimens.

2. How long does it take to see a reduction in testosterone?
Clinical studies show that serum testosterone typically declines within two to four weeks of consistent daily dosing, although individual response may vary.

3. Can Lucicyp be taken with other medications?
Patients should disclose all current medications to their healthcare provider, as interactions with other anti‑androgens, certain antidepressants, or hormonal therapies may affect efficacy and safety.

4. Are there dietary restrictions while using this medication?
No specific dietary restrictions are required, but patients are encouraged to maintain a balanced diet and stay hydrated to support overall health during treatment.

5. What should I do if I miss a dose?
If a dose is missed, the patient should take it as soon as remembered unless it is near the time of the next scheduled dose; in that case, the missed dose should be skipped and the regular schedule resumed.

Related Products

• Lucipona 15 mg (ponatinib)
• Lucipona 45 mg (ponatinib)
• Cyproterone 50mg
• LuciFine 10mg (Finerenone)
• Finerenone 10 mg Tablet (LuciFine)
• Ponatinib 15 mg
• Ponatinib 45 mg